The impact of sex and gender on disease progression, from developmental origins

从发育起源来看性别和性别对疾病进展的影响

基本信息

  • 批准号:
    10260551
  • 负责人:
  • 金额:
    $ 57.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-10 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Abstract The maternal fetal interface is hormonal and immunologically rich environment that is important for normal placentation during the first trimester of pregnancy. This is also where adult diseases have developmental origins. Both the hormonal and immunologic milieus at this stage of gestation are already sexually dimorphic. We identified sexually dimorphic gene expression globally and among individual cell types of the first trimester placenta impacted by signaling at the maternal fetal interface, which includes members of the TGF-β superfamily, specifically TGFβ-1 and BMPs in males. Among individual cell types, ligands from the CCL family were most highly representative in females whereas IL1RN and MMP9 were highly expressed in males, with their corresponding receptors present on the maternal surface. Dihydrotestosterone, which is only produced by the male fetus, in addition to TGFβ1 and estradiol were identified as significant upstream regulators in individual cell types of the first trimester placenta. However, the hormonal environment may not be the only biologically sex different factor influencing the immune system, as we have also identified key transcription regulators in early gestation that may account for developmental origins of immune disease. Throughout the lifespan, hormones have been implicated to play a significant role in immune dysfunction and development of disease, as overall there is a higher prevalence of autoimmune diseases in females, such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis. Yet men are more likely to develop ankylosing spondylitis. Furthermore, males have increased prevalence of asthma compared to females in childhood, but the sexually dimorphic prevalence changes post-puberty, suggesting testosterone may be protective. There are also potential gender differences that influence the immune system. However, post puberty, hormonal regulation becomes sexually dimorphic again and it becomes difficult to separate the influence of hormones which is a function of biologic sex on the immune system from the influence of gender which is due to external influences. Therefore, in order to better understand the influence of biological sex during developmental origins of immune function, including the effect of the hormonal milieu, we intend to identify sex specific transcriptional regulatory signatures in the first trimester placenta. Furthermore, since sex hormones ar e not dimorphic in early childhood, prior to puberty, we intend to better understand the influence of gender on developmental differences of the immune system, prior to hormonal influences, to identify the critical drivers of sexual dimorphism in immune function. Our goal is to identify sex unique regulators of immune dysfunction that can ultimately be used as a more personalized approach to treating immunologic diseases.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margareta Pisarska其他文献

Margareta Pisarska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margareta Pisarska', 18)}}的其他基金

The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10469623
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10687088
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10062754
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10675005
  • 财政年份:
    2019
  • 资助金额:
    $ 57.07万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10252913
  • 财政年份:
    2019
  • 资助金额:
    $ 57.07万
  • 项目类别:
Noncoding RNA regulation of the human placental transcriptome among the sexes
性别中人胎盘转录组的非编码RNA调控
  • 批准号:
    9308742
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8529827
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    9067824
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8735977
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Effects of fetal sex on the first trimester transcriptome
胎儿性别对妊娠早期转录组的影响
  • 批准号:
    8994647
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:

相似海外基金

Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis
强直性脊柱炎中细胞毒性 T 细胞耗竭的失调
  • 批准号:
    488673
  • 财政年份:
    2023
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
Investigating the Role of T cell surface sialoglycans in Ankylosing spondylitis immunopathogenesis
研究 T 细胞表面唾液酸聚糖在强直性脊柱炎免疫发病机制中的作用
  • 批准号:
    486602
  • 财政年份:
    2022
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Studentship Programs
Prospective Evaluation of Autoimmune Ear Disease in Ankylosing Spondylitis & Spondyloarthritis
强直性脊柱炎自身免疫性耳病的前瞻性评估
  • 批准号:
    450958
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Studentship Programs
T cell trafficking and specificity in ankylosing spondylitis
强直性脊柱炎中的 T 细胞运输和特异性
  • 批准号:
    380299
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
Identification of disease-related T cell clones and arthritogenic antigens in ankylosing spondylitis
强直性脊柱炎疾病相关 T 细胞克隆和致关节炎抗原的鉴定
  • 批准号:
    413277889
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Grants
Macrophage migration inhibitory factor (MIF) as a Crucial Regulatory Cytokine and Therapeutic Target in Ankylosing Spondylitis
巨噬细胞迁移抑制因子(MIF)作为强直性脊柱炎的关键调节细胞因子和治疗靶点
  • 批准号:
    397552
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Fellowship Programs
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : GNT1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Fellowships
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : 1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Fellowships
Personalized medicine for ankylosing spondylitis
强直性脊柱炎个体化用药
  • 批准号:
    365355
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
Development and application of a Mendelian randomization framework aimed at dissecting the biological basis of ankylosing spondylitis and other complex diseases
孟德尔随机化框架的开发和应用,旨在剖析强直性脊柱炎和其他复杂疾病的生物学基础
  • 批准号:
    nhmrc : GNT1125200
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了